These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 15026334

  • 1. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP.
    Cancer Res; 2004 Mar 15; 64(6):1987-96. PubMed ID: 15026334
    [Abstract] [Full Text] [Related]

  • 2. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A.
    Cancer Res; 2005 Jan 15; 65(2):526-32. PubMed ID: 15695395
    [Abstract] [Full Text] [Related]

  • 3. Signaling through beta-catenin and Lef/Tcf.
    Novak A, Dedhar S.
    Cell Mol Life Sci; 1999 Oct 30; 56(5-6):523-37. PubMed ID: 11212302
    [Abstract] [Full Text] [Related]

  • 4. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J.
    Oncogene; 2001 Jan 11; 20(2):252-9. PubMed ID: 11313952
    [Abstract] [Full Text] [Related]

  • 5. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T, Ninomiya-Tsuji J, Matsumoto K.
    Mol Cell Biol; 2003 Feb 11; 23(4):1379-89. PubMed ID: 12556497
    [Abstract] [Full Text] [Related]

  • 6. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
    Novak A, Hsu SC, Leung-Hagesteijn C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R, Dedhar S.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4374-9. PubMed ID: 9539744
    [Abstract] [Full Text] [Related]

  • 7. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H, Mao J, Li L, Wu D.
    J Biol Chem; 1999 Oct 22; 274(43):30419-23. PubMed ID: 10521419
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S.
    Oncogene; 2001 Jan 04; 20(1):133-40. PubMed ID: 11244511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM.
    J Biol Chem; 2005 Apr 01; 280(13):13019-28. PubMed ID: 15668231
    [Abstract] [Full Text] [Related]

  • 11. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
    D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG.
    J Biol Chem; 2000 Oct 20; 275(42):32649-57. PubMed ID: 10915780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
    Morrison JA, Klingelhutz AJ, Raab-Traub N.
    J Virol; 2003 Nov 20; 77(22):12276-84. PubMed ID: 14581564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.
    Oloumi A, McPhee T, Dedhar S.
    Biochim Biophys Acta; 2004 Apr 01; 1691(1):1-15. PubMed ID: 15053919
    [Abstract] [Full Text] [Related]

  • 16. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ, Burgering BM, van de Wetering M, Clevers HC.
    Int Immunol; 1999 Mar 01; 11(3):317-23. PubMed ID: 10221643
    [Abstract] [Full Text] [Related]

  • 17. Developmental expression of Wnt signaling factors in mouse brain.
    Coyle-Rink J, Del Valle L, Sweet T, Khalili K, Amini S.
    Cancer Biol Ther; 2002 Mar 01; 1(6):640-5. PubMed ID: 12642687
    [Abstract] [Full Text] [Related]

  • 18. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S, Troussard AA, McPhee TR, Mulholland DJ, Dedhar S.
    J Cell Biol; 2001 Jun 11; 153(6):1161-74. PubMed ID: 11402061
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.
    Hepatology; 2002 Dec 11; 36(6):1528-36. PubMed ID: 12447879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.